VITX .025 Opening in USA Vitana-X to Seek FDA Approval to Launch Products in the U.S. Share this article now Company Update: https://www.accesswire.com/625966/Vitana-X-to-Seek-FDA-Approval-to-Launch-Products-in-the-US Vitana-X Europe's revenue will be included in its quarterly results, which is due by February 28, 2021. https://www.nasdaq.com/press-release/gh-capitals-vitana-x-closes-acquisition-of-its-licensee-in-europe-2020-12-21 https://investorshub.advfn.com/uimage/uploads/2021/2/6/vjtnicbd.jpg https://investorshub.advfn.com/uimage/uploads/2021/2/7/gfttnpacks.jpg https://investorshub.advfn.com/uimage/uploads/2021/2/9/okpnkrviva.png https://investorshub.advfn.com/uimage/uploads/2020/9/21/uqqeyDNA_Body_Transformer.png https://investorshub.advfn.com/uimage/uploads/2020/9/21/eisbdDNA_Body_Transformer_-_1.png